Related Experiment Video

Updated: May 13, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Outcomes of phenylketonuria with relevance to follow-up

F J van Spronsen1, A Bélanger-Quintana

  • 1Beatrix Children's Hospital, University Medical Center of Groningen, Groningen, The Netherlands, f.j.van.spronsen@bkk.umcg.nl.

JIMD Reports
|February 23, 2013
PubMed

Insights

Current guidelines for phenylketonuria (PKU) and hyperphenylalaninaemia management lack consensus. This study proposes an interdisciplinary follow-up scheme to improve patient care and calls for further research.

Area of Science:

  • Metabolic disorders
  • Clinical genetics
  • Pediatric medicine

Background:

  • There is a lack of international consensus on clinical follow-up for phenylketonuria (PKU) and hyperphenylalaninaemia.
  • Existing guidelines primarily focus on blood phenylalanine levels, neglecting comprehensive patient monitoring.
  • A standardized, interdisciplinary approach is needed for effective PKU management across different age groups.

Purpose of the Study:

  • To propose an interdisciplinary scheme for the clinical follow-up of individuals with PKU and hyperphenylalaninaemia.
  • To initiate a discussion among professionals, patients, and parents for refining PKU management strategies.
  • To highlight areas requiring further research in PKU patient care.

Main Methods:

  • Review of current practices and identification of gaps in PKU follow-up guidelines.
  • Development of a proposed interdisciplinary monitoring scheme.
  • Emphasis on collaboration between clinicians, dietitians, social health workers, psychologists, and neurologists.

Main Results:

  • A proposed follow-up scheme integrating various clinical investigations and professional consultations.
  • Identification of the need for regular contact with a multidisciplinary team.
  • Acknowledgement that the proposed scheme is a starting point for further refinement.

Conclusions:

  • An interdisciplinary approach is essential for optimal follow-up of PKU and hyperphenylalaninaemia patients.
  • The proposed scheme provides a framework for discussion and improvement of current management practices.
  • Further research is necessary to address unanswered questions and optimize PKU management throughout a patient's life.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...